Germany· DE-A57-5a477374eea52397
Ibandronsäure Onkovis
A medicinal product containing ibandronate sodium monohydrate, registered in Germany by Onkovis Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ibandronate Sodium Monohydrate
- Manufacturer
- Onkovis Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ibandronate sodium monohydrate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBONDRONATAtnahs Pharma Netherlands B.V., Amsterdam
- FinlandBondenzaRoche Registration Limited
- BelgiumBondronat 2 mg/2 mlAtnahs Pharma Netherlands
- United StatesIbandronate sodiumA-S Medication Solutions
- IrelandIbandronic Acid 150 mg film-coated tabletsAccord Healthcare Ireland Ltd.
- SwedenEtanorden 150 mg Filmdragerad tablettGedeon Richter Plc
- IcelandIbandronic acid WHWilliams & Halls ehf
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Ibandronsäure +pharma, Ibandronsäure Actavis
- Czechia · Ibandronic Acid Viatris
- Finland · Ibandronate Ratiopharm
- United Kingdom (Northern Ireland) · Ibandronic Acid Noridem Enterprises
- Greece · Ibondem
- Croatia · Ostea
- Hungary · Bonessa, Etanorden
- Ireland · Ibandronic Acid Noridem Enterprises
- Iceland · Ibandronic Acid Wh
- Italy · Acido Ibandronico Mylan
- Latvia · Ossica
- Netherlands · Ibandroninezuur Synthon
- Poland · Ibandronic Acid Noridem, Osagrand
- Portugal · Ácido Ibandrónico Gedeon Richter
- Romania · Ossica
- Sweden · Ibandronate Bluefish
- Slovakia · Ossica
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4ab0a00f-60e7-406b-89d4-8dbe25eb4142 GET /v1/drugs/4ab0a00f-60e7-406b-89d4-8dbe25eb4142?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ibandronate Sodium Monohydrate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ibandronate sodium monohydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.